Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 8NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 924Neoplasms 614Breast Neoplasms 613Colorectal Neoplasms 452Neoplasm Metastasis 398Ovarian Neoplasms 333Melanoma 316Prostatic Neoplasms 315Lung Neoplasms 293Multiple Myeloma 292Recurrence 280Squamous Cell Carcinoma of Head and Neck 247Stomach Neoplasms 232Pancreatic Neoplasms 231Leukemia, Myeloid, Acute 223Triple Negative Breast Neoplasms 192Endometrial Neoplasms 191Carcinoma, Renal Cell 183Lymphoma, Non-Hodgkin 179Carcinoma, Hepatocellular 177Small Cell Lung Carcinoma 164Leukemia, Lymphocytic, Chronic, B-Cell 158Advanced Solid Tumors 157Lymphoma, Follicular 150Lymphoma, Large B-Cell, Diffuse 141Urinary Bladder Neoplasms 140Lymphoma 138Advanced Solid Tumor 137Uterine Cervical Neoplasms 135Glioblastoma 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Enteropathy-Associated T-Cell Lymphoma × 1 year × Clear all
NCT05475925 2026-04-17

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Dren Bio

Phase 1/2 Recruiting
200 enrolled
DermatologicLymphoidOther hematologic neoplasm

Subcutaneous panniculitis-like T-cell lymphoma, Leukemia, Lymphoma, Leukemia, Large Granular Lymphocytic, Lymphoma, Extranodal NK-T-Cell, Enteropathy-Associated T-Cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡